Low-dose prednisolone in first-line docetaxel for patients with metastatic castration-resistant prostate cancer: is there a clinical benefit?

Per Kongsted, Inge Marie Svane, Henriette Lindberg, Gedske Daugaard, Lisa Sengeløv

14 Citationer (Scopus)

Fingeraftryk

Dyk ned i forskningsemnerne om 'Low-dose prednisolone in first-line docetaxel for patients with metastatic castration-resistant prostate cancer: is there a clinical benefit?'. Sammen danner de et unikt fingeraftryk.

Medicin og biovidenskab